Chapel Hill, NC, United States of America

Yu Mi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yu Mi in Surgical and Immunological Applications

Introduction

Yu Mi is an accomplished inventor based in Chapel Hill, NC, with a focus on innovative solutions in the medical field. He holds two patents that address significant challenges in post-surgical recovery and immunotherapy.

Latest Patents

His latest patents include "Compositions and methods for inhibiting post-surgical adhesions." This invention describes methods employing particle compositions that form a composite membrane to inhibit post-surgical adhesions. The method involves treating a surgical site with a particle formulation that includes targeting and scaffolding particles, which are crosslinked to create a protective membrane. This membrane effectively reduces the formation of adhesions at the surgical site.

Another notable patent is "Methods and compositions for activation of T cells using nanoparticles conjugated with multiple ligands for binding receptors on T cells." This invention provides methods and compositions that utilize particles with at least two different targeting agents, each binding to distinct protein receptors on T cell surfaces. This innovative approach enhances the activation of T cells, which is crucial for effective immunotherapy.

Career Highlights

Yu Mi is affiliated with the University of North Carolina at Chapel Hill, where he contributes to research and development in the field of medical innovations. His work is characterized by a commitment to improving patient outcomes through advanced technologies.

Collaborations

Yu Mi collaborates with Andrew Zhuang Wang, leveraging their combined expertise to drive forward innovative research and development in their respective fields.

Conclusion

Yu Mi's contributions to medical technology through his patents demonstrate his dedication to addressing critical health challenges. His work in inhibiting post-surgical adhesions and enhancing T cell activation showcases the potential of innovative solutions in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…